SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Abiomed Inc. – ‘8-K’ for 8/4/22 – ‘XML’

On:  Thursday, 8/4/22, at 7:14am ET   ·   For:  8/4/22   ·   Accession #:  950170-22-14469   ·   File #:  1-09585

Previous ‘8-K’:  ‘8-K’ on 6/21/22 for 6/17/22   ·   Next:  ‘8-K’ on 8/12/22 for 8/10/22   ·   Latest:  ‘8-K’ on / for 12/22/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/04/22  Abiomed Inc.                      8-K:2,9     8/04/22   11:778K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     61K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    538K 
 6: R1          Document and Entity Information                     HTML     46K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- abmd-20220804_htm                   XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- abmd-20220804_lab                     XML     53K 
 5: EX-101.PRE  XBRL Presentations -- abmd-20220804_pre              XML     33K 
 3: EX-101.SCH  XBRL Schema -- abmd-20220804                         XSD     11K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    18K 
11: ZIP         XBRL Zipped Folder -- 0000950170-22-014469-xbrl      Zip     42K 


‘XML’   —   XBRL Instance — abmd-20220804_htm


This Document is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="abmd-20220804.xsd" xlink:type="simple"/>
<context id="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000815094 </identifier>
</entity>
<period>
<startDate> 2022-08-04 </startDate>
<endDate> 2022-08-04 </endDate>
</period>
</context>
<dei:AmendmentFlag contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_25517d04-0bec-4f20-a8bd-20502bdf3bfa"> false </dei:AmendmentFlag>
<dei:EntityCentralIndexKey contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_08ecf011-aaef-4448-8eca-0cdf9beeaaee"> 0000815094 </dei:EntityCentralIndexKey>
<dei:DocumentType contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_b5fff3f4-f136-4927-97c7-2bcca835b158"> 8-K </dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_e7453236-3b78-4ebf-b31f-d7efcd495ab6"> 2022-08-04 </dei:DocumentPeriodEndDate>
<dei:EntityRegistrantName contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_f890e9cb-0221-40d1-995d-bf78883eaf03"> ABIOMED, Inc. </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_46f8f187-0baa-44bf-b2fa-2218e5ee6aa6"> DE </dei:EntityIncorporationStateCountryCode>
<dei:EntityFileNumber contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_18eadf22-6709-4101-b96f-1bc8038c0af4"> 001-09585 </dei:EntityFileNumber>
<dei:EntityTaxIdentificationNumber contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_c6d5cfa1-fa3d-4f74-bc84-73cc5857ef90"> 04-2743260 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_8d77f4ec-9bfd-4a4c-a897-99381aa365f4"> 22 Cherry Hill Drive </dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_0eeef30a-324a-49ca-86f8-a9788d3c127c"> Danvers </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_3b3a94c8-8ade-41c3-b09b-14d28aa6ddeb"> MA </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_e8a40d0c-3fcb-4b0f-a5fb-f1c6b1b9d1cb"> 01923 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_cd7718af-3197-451b-87b0-e7b63b42bdef"> 978 </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_1bff4102-5f1a-4db8-8330-337482996463"> 646-1400 </dei:LocalPhoneNumber>
<dei:Security12bTitle contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_292f44f1-2d1b-41e9-8f94-55177781e565"> Common Stock, $0.01 par value </dei:Security12bTitle>
<dei:TradingSymbol contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_8c30f520-2b1a-48bc-9448-339ee30c52d8"> ABMD </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_f0b83428-458c-4949-a5b6-1afb5f3c9c62"> NASDAQ </dei:SecurityExchangeName>
<dei:WrittenCommunications contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_54e335c3-c5dc-45f9-bbed-5614da306520"> false </dei:WrittenCommunications>
<dei:SolicitingMaterial contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_cca720ac-5337-4e28-b7f7-4dad11e877a8"> false </dei:SolicitingMaterial>
<dei:PreCommencementTenderOffer contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_9d95a3bd-ac60-4911-9f22-1c130d38b5b6"> false </dei:PreCommencementTenderOffer>
<dei:PreCommencementIssuerTenderOffer contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_e08d32b8-859d-427a-b912-b208488ede17"> false </dei:PreCommencementIssuerTenderOffer>
<dei:EntityEmergingGrowthCompany contextRef="C_cdcca0c7-8d4f-4d40-9f8f-a92fad41eeab" id="F_bd2ca8a1-8c7b-407e-bdb5-8f52455629e3"> false </dei:EntityEmergingGrowthCompany>
</xbrl>

Top
Filing Submission 0000950170-22-014469   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 1:41:04.1pm ET